retatrutide weight loss clinical Phase 3: 60% Achieved Surgical-Level Retatrutide Shows 28% Weight Loss

Research shows that about one in three people stop taking GLP-1s within the first year, and about half stop after one year

RetzlerRx products and partner formulations are selected as part of an evidence-based preventive longevity medicine approach

We also offer insulin to pump members whose supplies are being billed to their Medicare Part D benefit

What to track Keep a simple daily log that records bowel movement frequency (how many per day), stool consistency (use the Bristol Stool Scale, aiming for Type 3 or 4), ease of passage (straining versus comfortable), abdominal symptoms (bloating, cramping, gas), water intake (in ounces), fiber intake (approximate grams), exercise (type and duration), and any supplements or laxatives used

On the margin, loss of lean mass in older adults is coupled to loss of strength and function

Additionally, participants completed a three-day food record using the 2024 version of the Automated Self-Administered Dietary Assessment Tool, which was used to calculate each individual's average intake